Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5271700
Max Phase: Preclinical
Molecular Formula: C16H12ClF3N2O2
Molecular Weight: 356.73
Associated Items:
ID: ALA5271700
Max Phase: Preclinical
Molecular Formula: C16H12ClF3N2O2
Molecular Weight: 356.73
Associated Items:
Canonical SMILES: O=C1N(c2ccc(O)cc2)CCN1c1ccc(Cl)c(C(F)(F)F)c1
Standard InChI: InChI=1S/C16H12ClF3N2O2/c17-14-6-3-11(9-13(14)16(18,19)20)22-8-7-21(15(22)24)10-1-4-12(23)5-2-10/h1-6,9,23H,7-8H2
Standard InChI Key: GMYUBUKYNVZGSJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 356.73 | Molecular Weight (Monoisotopic): 356.0539 | AlogP: 4.51 | #Rotatable Bonds: 2 |
Polar Surface Area: 43.78 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.31 | CX Basic pKa: | CX LogP: 3.85 | CX LogD: 3.85 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.86 | Np Likeness Score: -1.19 |
1. Du X, Wang M, Hu X, Nie T, Zhu M, Zhang G, You X, Wang Y.. (2022) Synthesis and biological evaluation of novel N, N'-diarylurea derivatives as potent antibacterial agents against MRSA., 75 [PMID:36067930] [10.1016/j.bmcl.2022.128975] |
Source(1):